Long Focus Capital Management LLC lowered its holdings in Insmed Incorporated (NASDAQ:INSM – Free Report) by 33.8% during the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 215,057 shares of the biopharmaceutical company’s stock after selling 109,943 shares during the period. Long Focus […]
Insmed (NASDAQ:INSM – Get Free Report) had its price objective upped by analysts at Guggenheim from $50.00 to $52.00 in a research report issued on Tuesday, FlyOnTheWall reports. Guggenheim’s price objective would indicate a potential upside of 94.47% from the stock’s current price. A number of other equities research analysts have also recently commented on […]
Panagora Asset Management Inc. increased its holdings in Insmed Incorporated (NASDAQ:INSM – Free Report) by 8.4% in the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 448,581 shares of the biopharmaceutical company’s stock after acquiring an additional 34,862 shares during the quarter. […]
Insmed (NASDAQ:INSM – Get Free Report) and Lyell Immunopharma (NASDAQ:LYEL – Get Free Report) are both medical companies, but which is the superior business? We will compare the two businesses based on the strength of their earnings, valuation, analyst recommendations, profitability, dividends, institutional ownership and risk. Valuation & Earnings This table compares Insmed and Lyell […]
Insmed (NASDAQ:INSM) Earns Sell Rating from Analysts at StockNews com theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.